Park Avenue Securities’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,524
| Closed | -$201K | – | 1335 |
|
|
2024
Q4 | $201K | Buy |
1,524
+30
| +2% | +$3.96K | ﹤0.01% | 1433 |
|
|
2024
Q3 | $218K | Buy |
+1,494
| New | +$218K | ﹤0.01% | 1315 |
|
|
2024
Q1 | – | Sell |
-1,772
| Closed | -$241K | – | 1385 |
|
|
2023
Q4 | $241K | Sell |
1,772
-172
| -9% | -$23.4K | ﹤0.01% | 1205 |
|
|
2023
Q3 | $238K | Buy |
+1,944
| New | +$238K | ﹤0.01% | 1151 |
|
|
2022
Q1 | – | Sell |
-6,769
| Closed | -$1.03M | – | 1149 |
|
|
2021
Q4 | $1.03M | Buy |
6,769
+653
| +11% | +$99.7K | 0.02% | 458 |
|
|
2021
Q3 | $989K | Sell |
6,116
-91
| -1% | -$14.7K | 0.02% | 415 |
|
|
2021
Q2 | $1.02M | Sell |
6,207
-3,747
| -38% | -$613K | 0.02% | 380 |
|
|
2021
Q1 | $1.5M | Sell |
9,954
-445
| -4% | -$67K | 0.04% | 252 |
|
|
2020
Q4 | $1.58M | Sell |
10,399
-510
| -5% | -$77.2K | 0.04% | 193 |
|
|
2020
Q3 | $1.48M | Buy |
10,909
+2,392
| +28% | +$324K | 0.05% | 170 |
|
|
2020
Q2 | $1.16M | Buy |
+8,517
| New | +$1.16M | 0.04% | 169 |
|
|
2020
Q1 | – | Sell |
-8,601
| Closed | -$1.04M | – | 421 |
|
|
2019
Q4 | $1.04M | Buy |
8,601
+4,418
| +106% | +$533K | 0.04% | 175 |
|
|
2019
Q3 | $416K | Buy |
+4,183
| New | +$416K | 0.02% | 286 |
|